Teichomycin A2-3
(BJNLLBUOHPVGFT-VPMXZCLFSA-N)
Structure
- SMILES
- CCCCCCCCCC(=O)N[C@H]1[C@@H](O[C@@H]([C@H]([C@@H]1O)O)CO)Oc1c2cc3cc1Oc1ccc(cc1Cl)C[C@@H]1C(=O)N[C@H](C(=O)N[C@H]3C(=O)N[C@H]3C(=O)N[C@@H]([C@@H](c4ccc(O2)c(Cl)c4)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2NC(=O)C)O)O)C(=O)N[C@H](c2c(c4cc3ccc4O)c(cc(c2)O)O[C@H]2O[C@H](CO)[C@H]([C@@H]([C@@H]2O)O)O)C(=O)O)c2cc(O)cc(c2)Oc2cc([C@@H](C(=O)N1)N)ccc2O
- Molecular Formula:
- C88H97Cl2N9O33
- Molecular Weight:
- 1879.660
- Log P:
- 4.6185
- Hydrogen Bond Acceptor:
- 42
- Hydrogen Bond Donor:
- 24
- TPSA:
- 662.41
- CAS Number(s):
- 61036-62-2
Synonym(s)
1.
Teichomycin A2-3
2.
(1S,2R,19R,22S,34S,37R,40R,52R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-azaniumyl-5,15-dichloro-64-[(2S,3R,4R,5S,6R)-3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abscess | SIDER | ||
| 2 | Agranulocytosis | SIDER | ||
| 3 | Anaphylactic shock | SIDER | ||
| 4 | Angioedema | SIDER | ||
| 5 | Bronchospasm | SIDER | ||
| 6 | Chills | SIDER | ||
| 7 | Deafness | SIDER | ||
| 8 | Dermatitis | SIDER | ||
| 9 | Dizziness | SIDER | ||
| 10 | Eosinophilia | SIDER | ||
| 11 | Erythema Multiforme | SIDER | ||
| 12 | Erythema | SIDER | ||
| 13 | Flushing | SIDER | ||
| 14 | Headache | SIDER | ||
| 15 | Hypersensitivity | SIDER | ||
| 16 | Leukopenia | SIDER | ||
| 17 | Local reaction | SIDER | ||
| 18 | Nausea | SIDER | ||
| 19 | Neutropenia | SIDER | ||
| 20 | Pain | SIDER | ||
| 21 | Phlebitis | SIDER | ||
| 22 | Pruritus | SIDER | ||
| 23 | Redness | SIDER | ||
| 24 | Stevens-Johnson Syndrome | SIDER | ||
| 25 | Thrombocytopenia | SIDER | ||
| 26 | Thrombophlebitis | SIDER | ||
| 27 | Tinnitus | SIDER | ||
| 28 | Toxic Epidermal Necrolysis | SIDER | ||
| 29 | Transaminases increased | SIDER | ||
| 30 | Urticaria | SIDER | ||
| 31 | Vertigo | SIDER | ||
| 32 | Vomiting | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.